These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1864973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P, van den Maagdenberg AM, Boomsma DI, Stalenhoef AF, Smelt AH, Kastelein JJ, Marais AD, Frants RR, Havekes LM.
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [Abstract] [Full Text] [Related]

  • 3. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 4. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
    Mulder M, van der Boom H, de Knijff P, Braam C, van den Maagdenberg A, Leuven JA, Havekes LM.
    Atherosclerosis; 1994 Aug 01; 108(2):183-92. PubMed ID: 7980718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
    Smelt AH, de Beer F.
    Semin Vasc Med; 2004 Aug 01; 4(3):249-57. PubMed ID: 15630634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ, Bergeron J, Gagné JM, Gagné C, Couture P.
    Metabolism; 2005 Aug 01; 54(8):1014-9. PubMed ID: 16092050
    [Abstract] [Full Text] [Related]

  • 9. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM.
    Hum Mutat; 1994 Aug 01; 4(3):178-94. PubMed ID: 7833947
    [Abstract] [Full Text] [Related]

  • 10. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH.
    Ned Tijdschr Geneeskd; 2003 Jan 25; 147(4):157-9. PubMed ID: 12635547
    [Abstract] [Full Text] [Related]

  • 11. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1994 Apr 25; 93(4):1403-10. PubMed ID: 8163645
    [Abstract] [Full Text] [Related]

  • 12. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR.
    J Biol Chem; 1993 May 15; 268(14):10540-5. PubMed ID: 7683682
    [Abstract] [Full Text] [Related]

  • 13. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ, Pearce NJ, Bergö M, Staels B, Yates JW, Gribble AD, Bond BC, Hofker MH, Havekes LM, Groot PH.
    Arzneimittelforschung; 1998 Apr 16; 48(4):396-402. PubMed ID: 9608883
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U.
    Hum Genet; 1986 Jun 16; 73(2):157-63. PubMed ID: 3721502
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Apolipoprotein E polymorphism and plasma lipid, lipoprotein, apolipoprotein levels in 291 children of Changsha].
    Xiang W, Zhao S, Peng D.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Jun 16; 24(3):232-6. PubMed ID: 12016791
    [Abstract] [Full Text] [Related]

  • 20. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G, Funke H, Weng W, Assmann G, Lackner KJ, Ziegler R.
    Eur J Clin Invest; 1992 Sep 16; 22(9):599-608. PubMed ID: 1360898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.